Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
New Haven Pharmaceuticals
company
About
New Haven Pharmaceuticals develops prescription pharmaceuticals that utilize drugs or GRAS active pharmaceutical ingredients.
- 11 - 50
Details
- Last Funding Type
- Debt Financing
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$25.17M
New Haven Pharmaceuticals has raised a total of
$25.17M
in funding over 2 rounds. Their latest funding was raised on
Aug 17, 2016 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 17, 2016 | Debt Financing | $602.22K | 1 | — | — | Detail |
| Oct 7, 2015 | Debt Financing | $6.30M | 1 | — | — | Detail |
| Oct 23, 2014 | Series B | $11.78M | 1 | — | — | Detail |
| Dec 31, 2013 | Debt Financing | — | 1 | — | — | Detail |
| Oct 29, 2012 | Series A | $6.49M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
New Haven Pharmaceuticals is funded by 3 investors.
Advantage Capital
and Horizon Technology Finance
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Debt Financing |
Horizon Technology Finance
|
— | Debt Financing |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
